ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

371
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
bullishCelltrion Inc09 Sep 2023 18:29

Progress of Merger Between Celltrion Inc and Celltrion Healthcare & Appraisal Rights Issue

Although some investors are likely to exercise their appraisal rights in this merger between Celltrion Inc and Celltrion Healthcare, we attach a...

Logo
Douglas Kim
505 Views
Share
bullishCelltrion Inc01 Sep 2023 08:51

(Mostly) Asia M&A, Aug 2023: Celltrion Inc/Healthcare, Itochu Techno, UMW, Boustead, SK Rent

For the month of August, 11 new deals were discussed on Smartkarma with an overall deal size of ~US$29bn. The average premium for the new deals...

Share
bullishCelltrion Inc20 Aug 2023 07:00

(Mostly) Asia-Pac Weekly Risk Arb Wrap: Celltrion, Sanei Architecture, T&K Toka, MPI, Chindata

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Share
bullishCelltrion Inc17 Aug 2023 18:43

Celltrion Merger: Index Implications

Celltrion and Celltrion Healthcare will merge before the end of the year. Both stocks have dropped and shorts have covered. There will be...

Logo
Brian Freitas
557 Views
Share
bullishCelltrion Inc16 Jul 2023 07:00

Last Week in Event SPACE: Celltrion, Fast Retailing, Canon, Costa, Chindata

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Share
x